Properties of an ideal PET perfusion tracer: New PET tracer cases and data

Journal of Nuclear Cardiology

Volumn 19, Issue SUPPL. 1, 2012, Pages

  Maddahi, Jamshid ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLURPIRIDAZ F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; TECHNETIUM 99M; THALLIUM 201; TRACER; WATER O 15; DIAGNOSTIC AGENT; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ANGIOCARDIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CYCLOTRON; DIAGNOSTIC ACCURACY; DOSIMETRY; DRUG HALF LIFE; DRUG SAFETY; DRUG UPTAKE; EXERCISE TEST; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; ISOTOPE LABELING; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HEART; HEART DISEASE; IMAGE ENHANCEMENT; METHODOLOGY; SCINTISCANNING;

HEART; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; MYOCARDIAL PERFUSION IMAGING; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84861491722     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9491-8     Document Type: Review

References (19)

1. Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-72.
2. Bergman SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial perfusion in human subjects with Oxygen-15 labeled water and positron emission tomography. J Am Coll Cardiol 1989;14:639-52.
3. Huang SC, Williams BA, Krivokapich J, Araujo L, Phelps ME, Schelbert HR. Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. Am J Physiol 1989;256: H1156-64.
4. Glover DK, Gropler RJ. Journey to find the ideal PET flow tracer for clinical use: Are we there yet? J Nucl Cardiol 2007;14:765-8.
5. Garcia EV, Galt R, Faber TL, Chen J. Principles of nuclear cardiology. In: Dilsizian V, Narula J, editors. Atlas of nuclear cardiology, Chapter 1. 3rd ed. Philadelphia: Current Medicine LLC; 2009. p. 1-34.
6. Yalamanchili P, Wexler E, Hayes M, Yu M, Bozek J, Kagan M, et al. Mechanism of uptake and retention of F-18 BMS-747 158-02 in cardiomyocytes: A novel PET myocardial imaging agent. J Nucl Cardiol 2007;14:782-8.
7. Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, et al. BMS-747158-02: A novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007;14:789-98.
8. Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester H-J, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 2008;49:630-6.
9. Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, et al. Evaluation of the novel myocardial perfusion PET tracer 18FBMS747158- 02: Comparison to 13 N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-42.
10. Maddahi J, Czernin J, Lazewatsky J, Huang S-C, Dahlbom M, Schelbert H, et al. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med 2011;52:1490-8.
11. Maddahi J, Bengel F, Huang S-C, Czernin J, Schelbert H, Zhu Q, et al. Phase 1 rest-stress study of F-18 labeled BMS747158 myocardial perfusion PET tracer: Human safety, dosimetry, biodistribution, and myocardial imaging characteristics. J Nucl Med 2009;50:184 (abstract).
12. Case J, Maddahi J, Bengel F, Bateman T, Dahlbom M, Lazewatsky J. Imaging properties of F-18 labeled myocardial perfusion PET agent, BMS747158: Dosage, acquisition time and scanner type. J Nucl Med 2009;50:418 (abstract).
13. Maddahi J, Huang S-C, Schiepers C, Bengel F, Czernin J, Schelbert H, et al. Same-day rest-stress protocols for PET imaging with the new F-18 labeled BMS747158 myocardial perfusion tracer. J Nucl Med 2009;50:1173 (abstract).
14. Case J, Lazewatsky J, Hsu B-L, Maddahi J, Berman D, Bateman T. Automatic registration of F-18 labeled BMS-747158 stress and rest myocardial perfusion images using 6D cross-correlation optimization. J Nucl Med 2010;51:1687 (abstract).
15. Hsu B, Lazewatsky J, Bateman T, Devine M, Maddahi J, Berman D, et al. Cardiac phantom simulation of dose injection parameters for one-day rest/stress myocardial perfusion (MPI) PET imaging with BMS747158 tracer. J Nucl Med 2010;51:320 (abstract).
16. Lazewatsky J, Maddahi J, Berman D, Bhat G, Sinha S, Devine M, et al. Development of a method for the determination of dose ratio and minimum inter-injection interval for a one-day rest-stress protocol with BMS747158 PET myocardial perfusion agent. J Nucl Med 2010;51:600 (abstract).
17. Maddahi J, Czernin J, Ehlgen A, Lazewatsky J, Zhu Q, Phelps M. Comparison of F-18 labeled BMS747158 PET and Tc-99m labeled SPECT myocardial perfusion imaging for detection and evaluation of coronary artery disease. J Am Coll Cardiol 2010;55:A65.E616.
18. Schelbert HR. Quantification of myocardial blood flow: What is the clinical role? Cardiol Clin 2009;27:277-89.
19. Maddahi J, Huang S, Truong D, Lazewatsky JL, Ehlgen A, Schelbert H, et al. Preliminary results of absolute quantification of rest and stress myocardial blood flow with flurpiridaz F-18 PET in normal and coronary artery disease patients in a single-center study. J Nucl Cardiol 2010;17:743 (abstract).